Acadian Asset Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-604,784
| Closed | -$9.8M | – | 1909 |
|
|
2023
Q2 | $9.8M | Sell |
604,784
-198,301
| -25% | -$3.29M | 0.04% | 298 |
|
|
2023
Q1 | $14M | Sell |
803,085
-303,857
| -27% | -$5.46M | 0.06% | 257 |
|
|
2022
Q4 | $20.8M | Buy |
1,106,942
+133,524
| +14% | +$2.57M | 0.1% | 192 |
|
|
2022
Q3 | $17.2M | Buy |
973,418
+314,160
| +48% | +$5.45M | 0.09% | 193 |
|
|
2022
Q2 | $11.5M | Buy |
659,258
+241,307
| +58% | +$4.6M | 0.06% | 244 |
|
|
2022
Q1 | $8.74M | Buy |
417,951
+93,117
| +29% | +$1.78M | 0.04% | 339 |
|
|
2021
Q4 | $5.78M | Sell |
324,834
-207,176
| -39% | -$3.33M | 0.02% | 426 |
|
|
2021
Q3 | $7.5M | Sell |
532,010
-109,595
| -17% | -$1.7M | 0.03% | 363 |
|
|
2021
Q2 | $10.6M | Sell |
641,605
-133,114
| -17% | -$2.39M | 0.04% | 313 |
|
|
2021
Q1 | $14M | Buy |
774,719
+23,625
| +3% | +$466K | 0.05% | 276 |
|
|
2020
Q4 | $13.7M | Buy |
751,094
+33,323
| +5% | +$529K | 0.05% | 284 |
|
|
2020
Q3 | $9.14M | Sell |
717,771
-27,574
| -4% | -$352K | 0.04% | 328 |
|
|
2020
Q2 | $8.18M | Sell |
745,345
-9,155
| -1% | -$94.9K | 0.04% | 371 |
|
|
2020
Q1 | $7.88M | Buy |
754,500
+344,628
| +84% | +$4.44M | 0.05% | 298 |
|
|
2019
Q4 | $6.59M | Buy |
409,872
+44,984
| +12% | +$743K | 0.03% | 385 |
|
|
2019
Q3 | $5.72M | Buy |
364,888
+35,382
| +11% | +$588K | 0.02% | 444 |
|
|
2019
Q2 | $6.55M | Buy |
329,506
+77,605
| +31% | +$1.45M | 0.03% | 348 |
|
|
2019
Q1 | $4.24M | Buy |
251,901
+51,170
| +25% | +$887K | 0.02% | 475 |
|
|
2018
Q4 | $3.04M | Buy |
200,731
+7,507
| +4% | +$129K | 0.02% | 475 |
|
|
2018
Q3 | $3.88M | Sell |
193,224
-5,419
| -3% | -$115K | 0.02% | 420 |
|
|
2018
Q2 | $3.87M | Sell |
198,643
-80,536
| -29% | -$1.27M | 0.02% | 433 |
|
|
2018
Q1 | $3.81M | Buy |
279,179
+42,378
| +18% | +$558K | 0.02% | 454 |
|
|
2017
Q4 | $3.22M | Sell |
236,801
-36,606
| -13% | -$526K | 0.01% | 455 |
|
|
2017
Q3 | $4.3M | Sell |
273,407
-262,119
| -49% | -$4.23M | 0.02% | 389 |
|
|
2017
Q2 | $9.22M | Buy |
535,526
+101,043
| +23% | +$1.54M | 0.04% | 292 |
|
|
2017
Q1 | $6.62M | Buy |
434,483
+212,928
| +96% | +$3.14M | 0.03% | 361 |
|
|
2016
Q4 | $2.91M | Sell |
221,555
-207,014
| -48% | -$2.65M | 0.01% | 508 |
|
|
2016
Q3 | $4.85M | Sell |
428,569
-797,504
| -65% | -$9.58M | 0.02% | 377 |
|
|
2016
Q2 | $14.6M | Sell |
1,226,073
-1,122,456
| -48% | -$15.1M | 0.07% | 210 |
|
|
2016
Q1 | $35.8M | Buy |
2,348,529
+507,551
| +28% | +$7.7M | 0.18% | 143 |
|
|
2015
Q4 | $29.7M | Buy |
1,840,978
+1,451,447
| +373% | +$21.2M | 0.16% | 162 |
|
|
2015
Q3 | $4.86M | Buy |
389,531
+225,452
| +137% | +$3.1M | 0.03% | 394 |
|
|
2015
Q2 | $2.72M | Buy |
164,079
+127,284
| +346% | +$2.05M | 0.01% | 522 |
|
|
2015
Q1 | $588K | Buy |
+36,795
| New | +$609K | ﹤0.01% | 742 |
|
Other funds holding NXGN
GCL
UOC
WP
Acadian Asset Management's NXGN Position: Q3 2023 in Review
Acadian Asset Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 604,784 shares — an estimated $9.8M sold.
Acadian Asset Management first reported a position in NXGN in Q1 2015 and held it in 34 quarters. The position peaked at $35.8M in Q1 2016. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.
- Acadian Asset Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Acadian Asset Management sold 604,784 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $9.8M.
- Acadian Asset Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2015 and held it in 34 quarters.
- Acadian Asset Management's NextGen Healthcare, Inc. Common Stock position peaked at $35.8M in Q1 2016.
- 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.